François, Stéphanie <br/><br/>
Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Mar 2005 
 - 3633-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.174.6.3633  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Carrier Proteins--metabolism<br/>Caspase 3<br/>Caspases--metabolism<br/>DNA-Binding Proteins--metabolism<br/>Humans<br/>In Vitro Techniques<br/>Membrane Glycoproteins--agonists<br/>Mitochondria--drug effects<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>NF-kappa B--metabolism<br/>Neoplasm Proteins--metabolism<br/>Neutrophils--cytology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Receptors, Cell Surface--agonists<br/>Replication Protein C<br/>Signal Transduction<br/>Toll-Like Receptor 1<br/>Toll-Like Receptor 2<br/>Toll-Like Receptor 4<br/>Toll-Like Receptor 5<br/>Toll-Like Receptor 7<br/>Toll-Like Receptor 9<br/>Toll-Like Receptors<br/>bcl-Associated Death Protein